4 December 2020
Latham Advises Frontier Medicines in its Global Partnership with AbbVie
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Judith Hasko | Latham & Watkins LLP | Partner | strategic collaboration | Bay Area |
| Peggy Ni | Latham & Watkins LLP | Associate | strategic collaboration | Not stated |
| Kathleen Wells | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Amy Feinberg | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| Frances Stocks Allen | Latham & Watkins LLP | Associate | data privacy | London |
| Oliver Mobasser | Latham & Watkins LLP | Associate | data privacy | London |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Frontier Medicines, Corp.Joint venture party
- Counterparties
- AbbVie (Joint venture party)